As of 2025-12-24, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -8.40 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 40.17 USD, the upside of Cogent Biosciences Inc is -120.90%.
Based on its market price of 40.17 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 120.90%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.40 - -8.40 | -8.40 | -120.90% |
| P/E | (36.81) - (40.31) | (41.23) | -202.6% |
| DDM - Stable | (15.07) - (67.29) | (41.18) | -202.5% |
| DDM - Multi | (1.12) - (3.87) | (1.73) | -104.3% |
| Market Cap (mil) | 7,041.00 |
| Beta | 1.20 |
| Outstanding shares (mil) | 175.28 |
| Enterprise Value (mil) | 6,959.95 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.02% |
| Cost of Debt | 5.00% |
| WACC | 6.35% |